Novel dry powder inhalation system based on dispersion of lyophilisates.

Eur J Pharm Sci

Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-Universitaet Muenchen, Butenandtstr. 5, D-81377 Munich, Germany.

Published: May 2011

Dry powder inhalers and dry powder formulations experience a growing interest and are the subject of continuous further development. In this study the objective was to evaluate the possible aerosolization of lyophilisates by an air impact and to prove this new concept of creating individual inhalable particles from a coherent bulk at the time of inhalation. Therefore an output test system for disintegration of the lyophilisate and for delivery of the generated fine particles was developed. The output system uses compressed air at a preselectable pressure for reproducible generation of inhalable particles. In order to understand the aerosolization of lyophilisates by the air impact, different single excipient formulations of amino acids and sugars were investigated. Besides the characterization of the different formulations by microscopy and X-ray diffractometry, we focused mainly on the particle size distributions (PSD) of the dispersed particles. Thereby the geometric PSD was analyzed by laser diffraction, whereas the aerodynamic PSD was characterized by time of flight and Andersen cascade impactor analysis. The destruction of the porous structure of the lyophilisates resulted in large geometric particle sizes but aerodynamic particle sizes in the inhalable range with relatively large fine particle fractions (FPF) between 20% and 50% calculated as a percentage of the metered dose. Despite potential differences in freezing behavior and thus cake structure within lyophilization batches, we attained reproducible fine particle fractions. Overall, it is concluded that the controlled disintegration of lyophilisates into inhalable particles by an air impact is possible and substantial FPF are achieved. Therefore, the method represents a promising new dry powder inhalation technology.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejps.2011.03.005DOI Listing

Publication Analysis

Top Keywords

dry powder
16
air impact
12
inhalable particles
12
powder inhalation
8
aerosolization lyophilisates
8
lyophilisates air
8
particle sizes
8
fine particle
8
particle fractions
8
lyophilisates
5

Similar Publications

Objectives: This qualitative study explored public and prescriber awareness of pharmaceutical pollution in the water environment and eco-directed sustainable prescribing (EDSP) as a mitigation strategy to reduce the environmental impact of prescribing in Scotland.

Design: Focus groups explored prescriber and public perceptions of the topic. Common questions were asked through semistructured facilitation.

View Article and Find Full Text PDF

Macrophages are an integral part of the innate immune system and act as a first line of defense to pathogens; however, macrophages can be reservoirs for pathogens to hide and replicate. Tuberculosis, influenza virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are common diseases whose pathogens are uptaken into macrophages. Current treatments for diseases such as these are limited by the therapeutic delivery method, which typically involves systemic delivery in large, frequent doses.

View Article and Find Full Text PDF

The use of air-jet dry powder inhalers (DPIs) offers a number of advantages for the administration of pharmaceutical aerosols, including the ability to achieve highly efficient and potentially targeted aerosol delivery to the lungs of children using the oral or trans-nasal routes of administration. To better plan targeted lung delivery of pharmaceutical aerosols with these inhalers, more information is needed on the extrathoracic (ET) depositional loss in pediatric subjects when using relatively small (e.g.

View Article and Find Full Text PDF

In addition to the known therapeutic indications for cannabidiol, its administration by inhalation appears to be of great interest. Indeed, there is evidence of cannabidiol's efficacy in several physiological pathways, suggesting its potential for a wide range of applications for both local and systemic pulmonary administration like cancers. Significant advances in pulmonary drug delivery have led to innovative strategies to address the challenges of increasing the respirable fraction of drugs and standardizing inhalable products.

View Article and Find Full Text PDF

Preclinical model of Mycobacteroides abscessus lung disease by nose-only exposure of mice to bacterial powder aerosol.

Tuberculosis (Edinb)

January 2025

CSIR-Central Drug Research Institute, Lucknow, 226031, UP, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, UP, India. Electronic address:

The limitations of existing mouse models of lung infection with Mycobacteroides abscessus impede drug discovery and development. In contrast to current animal models that introduce NTM intravenously or by intranasal/intra-tracheal instillation or via bronchoscopy-guided insufflation, we developed a dry powder inhalation (DPI) of M. abscessus ATCC 19977 that generated paucibacillary lung infection and histopathology in immunocompetent mice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!